LipiFlow Approved for Treatment of Meibomian Gland Dysfunction, aka, Evaporative Dry Eye

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

LipiFlow Treatment for Meibomian Gland Dysfunction Approved by FDA

Posted By Dr. Ari Weitzner On July 12, 2011 @ 11:22 am In Dry Eye,Industry News,New Technologies | Comments Disabled

TearScience, Inc., announced yesterday that the FDA had cleared its LipiFlow® Thermal Pulsation System for the treatment of meibomian gland dysfunction (MGD), one of the leading causes of dry eye. The clearance enables TearScience to market and sell LipiFlow® to eye care physicians in the U.S. LipiFlow® will be available immediately, but on a limited basis in the U.S. through the end of 2011. LipiFlow® removes meibomian gland obstructions by applying directed energy to a patient’s eyelid during a 12-minute in-office treatment.

Click here ^[1] to learn more.

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/005695-lipiflow-treatment-for-meibomian-gland-dysfunction-approved-by-fda/

URLs in this post:

[1] Click here: http://www.lipiflow.com/en/2011/07/11/tearscience-gains-u-s-fda-clearance-for-the-lipiflow%c2%ae-thermal-pulsation-system-for-treating-evaporative-dry-eye/

Click here to print.